Generate Biomedicines, Inc.

NASDAQ:GENB

Asset Management

Financial Services
$10.38 +0.91%

+$0.13 today

Market cap
$1.34B
Beta
0.19
P/E (TTM)
-3.5
EPS (TTM)
-$4.06
52W Low $11.00High $16.75

Volume 1.05M

Average 0.55M

GENB Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

Generate Biomedicines, Inc.NASDAQ: GENB

Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Other current liabilities of $14.92M in Q1 FY2026

Q1 FY2026 other current liabilities was $14.92M.

Context

  • Other current liabilities amounted to 2.4% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$14.92M— QoQ
Last fiscal yearDec 2025
$16.43M+4.1% YoY
Other Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+4.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Current Liabilities history

USD · from the balance sheet

Latest · FY2025
16.43M USD
Year-over-year change
+4.1%
1-year CAGR
+4.1%

Other Current Liabilities vs competitors

How GENB compares with its peers on the latest reported figures

  • GENB's Mar 2026 other current liabilities of $14.92M is the 2nd highest of the 5 companies compared; the peer median is $8.3M.
  • Other current liabilities amounts to 2.4% of total assets for GENB, versus a peer median of 3.3%.
GENB Competitors Peer median
Other Current Liabilities for GENB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
INBXInhibrx Biosciences, Inc.Mar 2026$15.34M +464.5%+9.3%8.3%
GENBGenerate Biomedicines, Inc.Mar 2026$14.92M ——2.4%
STROSutro Biopharma, Inc.Mar 2026$8.38M -67.4%+14.7%3.5%
ABCLAbCellera Biologics Inc.Sep 2026$8.22M ——0.5%
ABSIAbsci CorporationMar 2026$6.27M -50.8%—3.2%
Peer median (excluding GENB) $8.3M-50.8%+12.0%3.3%

Competitors are the stored peer set for GENB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD

Generate Biomedicines, Inc.

NASDAQ:GENB

Intrinsic Alpha fair value

Locked

Current Price

$10.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.